RxDoctor Payments Data

Cristina Nevarez de Jesus, MD

Geriatric Medicine · San Juan, PRNPI 1588897755

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AstraZeneca at 47.9% of the total. Among geriatric medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,350in general payments, 2019–2025

Across 119 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Sanofi-aventis U.S. LLC$290
  • Boehringer Ingelheim$243
  • Johnson & Johnson$217
  • Bausch & Lomb Americas Inc.$125
  • PBG Puerto Rico LLC$122
  • plus $228 from 5 others

What the payments were for

  • Food & beverage$2,350100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca58$1,125
Sanofi-aventis U.S. LLC16$290
Boehringer Ingelheim10$243
Johnson & Johnson9$217
Bausch & Lomb Americas Inc.5$125
PBG Puerto Rico LLC10$122
Pfizer Pharmaceuticals LLC4$67
AbbVie2$58
Eli Lilly Export S.A. Puerto Rico Branch3$57
Lilly USA, LLC1$23
Mylan Specialty L.p.1$23

How this compares

$2,350 in reported general payments places this provider in the 90th percentile of 76 geriatric medicine providers in Puerto Rico.

See all geriatric medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$15,240
Medicare patients
64
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide132$151,131
Trijardy XrEmpaglifloz/Linaglip/Metformin129$108,708
FarxigaDapagliflozin Propanediol112$99,389
EliquisApixaban81$85,009
GlyxambiEmpagliflozin/Linagliptin88$84,580
JardianceEmpagliflozin56$70,904
XareltoRivaroxaban64$63,349
OzempicSemaglutide55$52,980
Synjardy XrEmpagliflozin/Metformin Hcl58$45,847
ProliaDenosumab26$45,277
OdefseyEmtricitab/Rilpiviri/Tenof Ala12$44,074
Janumet XrSitagliptin Phos/Metformin Hcl35$38,293
MounjaroTirzepatide17$38,151
Xigduo XrDapaglifloz Propaned/Metformin59$34,465
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$33,278

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTrijardy Xr, Glyxambi, Jardiance, Synjardy Xr, Tradjenta$243$355,435387 claims
Lilly USA, LLCTrulicity, Mounjaro$23$189,281149 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,125$119,678143 claims
Johnson & JohnsonXarelto$217$63,34964 claims
AbbVieSynthroid, Linzess$58$54,025332 claims
Sanofi-aventis U.S. LLCLantus$290$9,061112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 76 geriatric medicine providers in Puerto Rico.

Other geriatric medicine in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →